0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Plasma Derivatives Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-39G3887
Home | Market Reports | Health| Pharmacy
Global Blood Plasma Derivatives Market Insights and Forecast to 2028
BUY CHAPTERS

Global Blood Plasma Derivatives Market Research Report 2024

Code: QYRE-Auto-39G3887
Report
April 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Plasma Derivatives Market Size

The global Blood Plasma Derivatives market was valued at US$ 30890 million in 2023 and is anticipated to reach US$ 47030 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.

Blood Plasma Derivatives Market

Blood Plasma Derivatives Market

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Plasma Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma Derivatives.

Report Scope

The Blood Plasma Derivatives market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Plasma Derivatives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma Derivatives companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Blood Plasma Derivatives Market Report

Report Metric Details
Report Name Blood Plasma Derivatives Market
Accounted market size in 2023 US$ 30890 million
Forecasted market size in 2030 US$ 47030 million
CAGR 5.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Other End Users
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG, CSL Limited, Takeda, China Biologic Products, Kedrion Biopharma, BDI Pharma, Bayer AG, Hualan Biological Engineering
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Blood Plasma Derivatives companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Plasma Derivatives Market growing?

Ans: The Blood Plasma Derivatives Market witnessing a CAGR of 5.7% during the forecast period 2024-2030.

What is the Blood Plasma Derivatives Market size in 2030?

Ans: The Blood Plasma Derivatives Market size in 2030 will be US$ 47030 million.

Who are the main players in the Blood Plasma Derivatives Market report?

Ans: The main players in the Blood Plasma Derivatives Market are Grifols, SK Plasma, Fusion Health Care, Biotest AG, Green Cross Corporation, Baxter International, LFB, Octapharma AG, CSL Limited, Takeda, China Biologic Products, Kedrion Biopharma, BDI Pharma, Bayer AG, Hualan Biological Engineering

What are the Application segmentation covered in the Blood Plasma Derivatives Market report?

Ans: The Applications covered in the Blood Plasma Derivatives Market report are Hospitals, Clinics, Other End Users

What are the Type segmentation covered in the Blood Plasma Derivatives Market report?

Ans: The Types covered in the Blood Plasma Derivatives Market report are Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Albumin
1.2.3 Factor VIII
1.2.4 Factor IX
1.2.5 Immunoglobulin
1.2.6 Hyperimmune Globulin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Blood Plasma Derivatives Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Derivatives Market Perspective (2019-2030)
2.2 Blood Plasma Derivatives Growth Trends by Region
2.2.1 Global Blood Plasma Derivatives Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Plasma Derivatives Historic Market Size by Region (2019-2024)
2.2.3 Blood Plasma Derivatives Forecasted Market Size by Region (2025-2030)
2.3 Blood Plasma Derivatives Market Dynamics
2.3.1 Blood Plasma Derivatives Industry Trends
2.3.2 Blood Plasma Derivatives Market Drivers
2.3.3 Blood Plasma Derivatives Market Challenges
2.3.4 Blood Plasma Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Derivatives Players by Revenue
3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2019-2024)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2019-2024)
3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Derivatives Revenue
3.4 Global Blood Plasma Derivatives Market Concentration Ratio
3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2023
3.5 Blood Plasma Derivatives Key Players Head office and Area Served
3.6 Key Players Blood Plasma Derivatives Product Solution and Service
3.7 Date of Enter into Blood Plasma Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Derivatives Breakdown Data by Type
4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2019-2024)
4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2025-2030)
5 Blood Plasma Derivatives Breakdown Data by Application
5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2019-2024)
5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Plasma Derivatives Market Size (2019-2030)
6.2 North America Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Plasma Derivatives Market Size by Country (2019-2024)
6.4 North America Blood Plasma Derivatives Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Plasma Derivatives Market Size (2019-2030)
7.2 Europe Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Plasma Derivatives Market Size by Country (2019-2024)
7.4 Europe Blood Plasma Derivatives Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2019-2030)
8.2 Asia-Pacific Blood Plasma Derivatives Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Plasma Derivatives Market Size (2019-2030)
9.2 Latin America Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Plasma Derivatives Market Size by Country (2019-2024)
9.4 Latin America Blood Plasma Derivatives Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2019-2030)
10.2 Middle East & Africa Blood Plasma Derivatives Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Detail
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Plasma Derivatives Introduction
11.1.4 Grifols Revenue in Blood Plasma Derivatives Business (2019-2024)
11.1.5 Grifols Recent Development
11.2 SK Plasma
11.2.1 SK Plasma Company Detail
11.2.2 SK Plasma Business Overview
11.2.3 SK Plasma Blood Plasma Derivatives Introduction
11.2.4 SK Plasma Revenue in Blood Plasma Derivatives Business (2019-2024)
11.2.5 SK Plasma Recent Development
11.3 Fusion Health Care
11.3.1 Fusion Health Care Company Detail
11.3.2 Fusion Health Care Business Overview
11.3.3 Fusion Health Care Blood Plasma Derivatives Introduction
11.3.4 Fusion Health Care Revenue in Blood Plasma Derivatives Business (2019-2024)
11.3.5 Fusion Health Care Recent Development
11.4 Biotest AG
11.4.1 Biotest AG Company Detail
11.4.2 Biotest AG Business Overview
11.4.3 Biotest AG Blood Plasma Derivatives Introduction
11.4.4 Biotest AG Revenue in Blood Plasma Derivatives Business (2019-2024)
11.4.5 Biotest AG Recent Development
11.5 Green Cross Corporation
11.5.1 Green Cross Corporation Company Detail
11.5.2 Green Cross Corporation Business Overview
11.5.3 Green Cross Corporation Blood Plasma Derivatives Introduction
11.5.4 Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2019-2024)
11.5.5 Green Cross Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Detail
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Blood Plasma Derivatives Introduction
11.6.4 Baxter International Revenue in Blood Plasma Derivatives Business (2019-2024)
11.6.5 Baxter International Recent Development
11.7 LFB
11.7.1 LFB Company Detail
11.7.2 LFB Business Overview
11.7.3 LFB Blood Plasma Derivatives Introduction
11.7.4 LFB Revenue in Blood Plasma Derivatives Business (2019-2024)
11.7.5 LFB Recent Development
11.8 Octapharma AG
11.8.1 Octapharma AG Company Detail
11.8.2 Octapharma AG Business Overview
11.8.3 Octapharma AG Blood Plasma Derivatives Introduction
11.8.4 Octapharma AG Revenue in Blood Plasma Derivatives Business (2019-2024)
11.8.5 Octapharma AG Recent Development
11.9 CSL Limited
11.9.1 CSL Limited Company Detail
11.9.2 CSL Limited Business Overview
11.9.3 CSL Limited Blood Plasma Derivatives Introduction
11.9.4 CSL Limited Revenue in Blood Plasma Derivatives Business (2019-2024)
11.9.5 CSL Limited Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Blood Plasma Derivatives Introduction
11.10.4 Takeda Revenue in Blood Plasma Derivatives Business (2019-2024)
11.10.5 Takeda Recent Development
11.11 China Biologic Products
11.11.1 China Biologic Products Company Detail
11.11.2 China Biologic Products Business Overview
11.11.3 China Biologic Products Blood Plasma Derivatives Introduction
11.11.4 China Biologic Products Revenue in Blood Plasma Derivatives Business (2019-2024)
11.11.5 China Biologic Products Recent Development
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Company Detail
11.12.2 Kedrion Biopharma Business Overview
11.12.3 Kedrion Biopharma Blood Plasma Derivatives Introduction
11.12.4 Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2019-2024)
11.12.5 Kedrion Biopharma Recent Development
11.13 BDI Pharma
11.13.1 BDI Pharma Company Detail
11.13.2 BDI Pharma Business Overview
11.13.3 BDI Pharma Blood Plasma Derivatives Introduction
11.13.4 BDI Pharma Revenue in Blood Plasma Derivatives Business (2019-2024)
11.13.5 BDI Pharma Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Detail
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Blood Plasma Derivatives Introduction
11.14.4 Bayer AG Revenue in Blood Plasma Derivatives Business (2019-2024)
11.14.5 Bayer AG Recent Development
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Company Detail
11.15.2 Hualan Biological Engineering Business Overview
11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Introduction
11.15.4 Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2019-2024)
11.15.5 Hualan Biological Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Albumin
    Table 3. Key Players of Factor VIII
    Table 4. Key Players of Factor IX
    Table 5. Key Players of Immunoglobulin
    Table 6. Key Players of Hyperimmune Globulin
    Table 7. Key Players of Others
    Table 8. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Blood Plasma Derivatives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Blood Plasma Derivatives Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Blood Plasma Derivatives Market Share by Region (2019-2024)
    Table 12. Global Blood Plasma Derivatives Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Blood Plasma Derivatives Market Share by Region (2025-2030)
    Table 14. Blood Plasma Derivatives Market Trends
    Table 15. Blood Plasma Derivatives Market Drivers
    Table 16. Blood Plasma Derivatives Market Challenges
    Table 17. Blood Plasma Derivatives Market Restraints
    Table 18. Global Blood Plasma Derivatives Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Blood Plasma Derivatives Market Share by Players (2019-2024)
    Table 20. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)
    Table 21. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2023
    Table 22. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Blood Plasma Derivatives Product Solution and Service
    Table 25. Date of Enter into Blood Plasma Derivatives Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Blood Plasma Derivatives Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2019-2024)
    Table 29. Global Blood Plasma Derivatives Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Blood Plasma Derivatives Revenue Market Share by Type (2025-2030)
    Table 31. Global Blood Plasma Derivatives Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2019-2024)
    Table 33. Global Blood Plasma Derivatives Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Blood Plasma Derivatives Revenue Market Share by Application (2025-2030)
    Table 35. North America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Europe Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)
    Table 40. Europe Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Asia-Pacific Blood Plasma Derivatives Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2019-2024) & (US$ Million)
    Table 43. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2025-2030) & (US$ Million)
    Table 44. Latin America Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Latin America Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Latin America Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Middle East & Africa Blood Plasma Derivatives Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2025-2030) & (US$ Million)
    Table 50. Grifols Company Detail
    Table 51. Grifols Business Overview
    Table 52. Grifols Blood Plasma Derivatives Product
    Table 53. Grifols Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 54. Grifols Recent Development
    Table 55. SK Plasma Company Detail
    Table 56. SK Plasma Business Overview
    Table 57. SK Plasma Blood Plasma Derivatives Product
    Table 58. SK Plasma Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 59. SK Plasma Recent Development
    Table 60. Fusion Health Care Company Detail
    Table 61. Fusion Health Care Business Overview
    Table 62. Fusion Health Care Blood Plasma Derivatives Product
    Table 63. Fusion Health Care Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 64. Fusion Health Care Recent Development
    Table 65. Biotest AG Company Detail
    Table 66. Biotest AG Business Overview
    Table 67. Biotest AG Blood Plasma Derivatives Product
    Table 68. Biotest AG Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 69. Biotest AG Recent Development
    Table 70. Green Cross Corporation Company Detail
    Table 71. Green Cross Corporation Business Overview
    Table 72. Green Cross Corporation Blood Plasma Derivatives Product
    Table 73. Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 74. Green Cross Corporation Recent Development
    Table 75. Baxter International Company Detail
    Table 76. Baxter International Business Overview
    Table 77. Baxter International Blood Plasma Derivatives Product
    Table 78. Baxter International Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 79. Baxter International Recent Development
    Table 80. LFB Company Detail
    Table 81. LFB Business Overview
    Table 82. LFB Blood Plasma Derivatives Product
    Table 83. LFB Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 84. LFB Recent Development
    Table 85. Octapharma AG Company Detail
    Table 86. Octapharma AG Business Overview
    Table 87. Octapharma AG Blood Plasma Derivatives Product
    Table 88. Octapharma AG Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 89. Octapharma AG Recent Development
    Table 90. CSL Limited Company Detail
    Table 91. CSL Limited Business Overview
    Table 92. CSL Limited Blood Plasma Derivatives Product
    Table 93. CSL Limited Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 94. CSL Limited Recent Development
    Table 95. Takeda Company Detail
    Table 96. Takeda Business Overview
    Table 97. Takeda Blood Plasma Derivatives Product
    Table 98. Takeda Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 99. Takeda Recent Development
    Table 100. China Biologic Products Company Detail
    Table 101. China Biologic Products Business Overview
    Table 102. China Biologic Products Blood Plasma Derivatives Product
    Table 103. China Biologic Products Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 104. China Biologic Products Recent Development
    Table 105. Kedrion Biopharma Company Detail
    Table 106. Kedrion Biopharma Business Overview
    Table 107. Kedrion Biopharma Blood Plasma Derivatives Product
    Table 108. Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 109. Kedrion Biopharma Recent Development
    Table 110. BDI Pharma Company Detail
    Table 111. BDI Pharma Business Overview
    Table 112. BDI Pharma Blood Plasma Derivatives Product
    Table 113. BDI Pharma Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 114. BDI Pharma Recent Development
    Table 115. Bayer AG Company Detail
    Table 116. Bayer AG Business Overview
    Table 117. Bayer AG Blood Plasma Derivatives Product
    Table 118. Bayer AG Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 119. Bayer AG Recent Development
    Table 120. Hualan Biological Engineering Company Detail
    Table 121. Hualan Biological Engineering Business Overview
    Table 122. Hualan Biological Engineering Blood Plasma Derivatives Product
    Table 123. Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2019-2024) & (US$ Million)
    Table 124. Hualan Biological Engineering Recent Development
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Blood Plasma Derivatives Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Blood Plasma Derivatives Market Share by Type: 2023 VS 2030
    Figure 3. Albumin Features
    Figure 4. Factor VIII Features
    Figure 5. Factor IX Features
    Figure 6. Immunoglobulin Features
    Figure 7. Hyperimmune Globulin Features
    Figure 8. Others Features
    Figure 9. Global Blood Plasma Derivatives Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Blood Plasma Derivatives Market Share by Application: 2023 VS 2030
    Figure 11. Hospitals Case Studies
    Figure 12. Clinics Case Studies
    Figure 13. Other End Users Case Studies
    Figure 14. Blood Plasma Derivatives Report Years Considered
    Figure 15. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Blood Plasma Derivatives Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Blood Plasma Derivatives Market Share by Region: 2023 VS 2030
    Figure 18. Global Blood Plasma Derivatives Market Share by Players in 2023
    Figure 19. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma Derivatives as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2023
    Figure 21. North America Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Blood Plasma Derivatives Market Share by Country (2019-2030)
    Figure 23. United States Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Blood Plasma Derivatives Market Share by Country (2019-2030)
    Figure 27. Germany Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2019-2030)
    Figure 35. China Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Japan Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. South Korea Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. India Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Australia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Latin America Blood Plasma Derivatives Market Share by Country (2019-2030)
    Figure 43. Mexico Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Brazil Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2019-2030)
    Figure 47. Turkey Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 50. SK Plasma Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 51. Fusion Health Care Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 52. Biotest AG Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 53. Green Cross Corporation Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 54. Baxter International Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 55. LFB Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 56. Octapharma AG Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 57. CSL Limited Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 58. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 59. China Biologic Products Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 60. Kedrion Biopharma Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 61. BDI Pharma Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 62. Bayer AG Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 63. Hualan Biological Engineering Revenue Growth Rate in Blood Plasma Derivatives Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cell Signaling Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32I5919
Mon May 20 00:00:00 UTC 2024

Add to Cart

Global Keytruda Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4J8284
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Fc Fusion Protein for Eye Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11F10758
Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Nuclear Medicine Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8W14462
Sun May 19 00:00:00 UTC 2024

Add to Cart